Douglas J Swirsky
CIK 1375884 · CHIEF FINANCIAL OFFICER · last filed 2026-03-19
Douglas J Swirsky is a CHIEF FINANCIAL OFFICER who has filed 55 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing shows the insider sold $8.3K of MXCT on Mar 19, 2026. Across all open-market trades the lifetime net is +$206.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $225.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$225.6K
8
55
$206.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MXCT | CHIEF FINANCIAL OFFICER | 151,669 | $1.12 | $169.9K | $34.2K | 6 | 2026-03-19 |
| CLRB | Director | 25,000 | $2.23 | $55.8K | $26.0K | 6 | 2025-02-18 |
| MetaVia Inc. (NRBO) Delisted | Director | — | $2.36 | — | $0 | 1 | 2020-09-03 |
| Cellectar Biosciences, Inc. (CLRBZ) Delisted | Director | — | $0.12 | — | $0 | 4 | 2020-06-25 |
| Fibrocell Science, Inc. (FCSC) Delisted | Director | — | — | — | $0 | 7 | 2019-12-13 |
| Opus Genetics, Inc. (RNN) Delisted | President and CEO | 50,000 | — | — | $31.7K | 3 | 2019-01-30 |
| PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted | Director | — | — | — | $0 | 2 | 2018-05-23 |
| GENVEC INC (GNVC) Delisted | President & CEO | 252,500 | — | — | $114.1K | 20 | 2016-09-16 |
Recent Filings
55 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-19 | MXCT | Sell (S) | −10,142 | -$8.3K | EDGAR |
| 2025-08-13 | MXCT | Buy (P) | +50,000 | $64.5K | EDGAR |
| 2025-03-20 | MXCT | Sell (S) | −6,939 | -$22.1K | EDGAR |
| 2025-03-18 | MXCT | Grant (A) | +37,500 | $0 | EDGAR |
| 2025-02-18 | CLRB | Grant (A) | — | $0 | EDGAR |
| 2024-06-18 | CLRB | Grant (A) | — | $0 | EDGAR |
| 2024-03-19 | MXCT | Grant (A) | +81,250 | $0 | EDGAR |
| 2023-06-28 | CLRB | Grant (A) | — | $0 | EDGAR |
| 2023-03-28 | MXCT | Grant (A) | — | $0 | EDGAR |
| 2022-08-01 | CLRB | Grant (A) | — | $0 | EDGAR |